Loading…
Expression patterns of β-catenin in in situ and invasive breast cancer
Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was...
Saved in:
Published in: | European journal of surgical oncology 2001-02, Vol.27 (1), p.31-36 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333 |
---|---|
cites | cdi_FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333 |
container_end_page | 36 |
container_issue | 1 |
container_start_page | 31 |
container_title | European journal of surgical oncology |
container_volume | 27 |
creator | Karayiannakis, A.J. Nakopoulou, L. Gakiopoulou, H. Keramopoulos, A. Davaris, P.S. Pignatelli, M. |
description | Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was evaluated in 121 breast cancer specimens by immunohistochemistry. Its relationship to clinicopathological features was also investigated.Results Altered β-catenin expression was found in 68% of tumours. Lobular carcinomas showed abnormal β-catenin expression more frequently (77%) than ductal carcinomas (64%) with 46% of lobular cases showing complete absence of β-catenin immunoreactivity. Cytoplasmic β-catenin localization was seen only in ductal carcinomas. Aberrant β-catenin expression was observed in 54% of ductal carcinomas in situ with highly concordant β-catenin expression patterns in the nearby in situ and invasive components. Conclusions Quantitative and qualitative changes in β-catenin expression occur in a considerable proportion of in situ and invasive ductal carcinomas and are more prominent in invasive lobular carcinomas. |
doi_str_mv | 10.1053/ejso.1999.1017 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70689604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S074879839991017X</els_id><sourcerecordid>70689604</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333</originalsourceid><addsrcrecordid>eNp1kEFLwzAUx4Mobk6vHqUnb51JkzbJUcacwsCLnkOavELG1tYkHfq1_CB-JlM68CQEXkJ-7897P4RuCV4SXNIH2IVuSaSU6Un4GZqTkhZ5QUp-juaYM5FzKegMXYWwwxhLyuUlmhFS0PQn52iz_uw9hOC6Nut1jODbkHVN9vOdGx2hdW02neDikOnWpvtRB3eErPagQ8yMbg34a3TR6H2Am1NdoPen9dvqOd--bl5Wj9vcUIZjXjRG0KrgFRhLTUU0M5RXRRqUlbgmtLSMALZcSiywYI2RVFS1Nsw2pm4opQt0P-X2vvsYIER1cMHAfq9b6IagOK6ErDBL4HICje9C8NCo3ruD9l-KYDWqU6M6NapTo7rUcHdKHuoD2D_85CoBYgIg7Xd04FUwDtLy1nkwUdnO_Zf9Cz2kfcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70689604</pqid></control><display><type>article</type><title>Expression patterns of β-catenin in in situ and invasive breast cancer</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Karayiannakis, A.J. ; Nakopoulou, L. ; Gakiopoulou, H. ; Keramopoulos, A. ; Davaris, P.S. ; Pignatelli, M.</creator><creatorcontrib>Karayiannakis, A.J. ; Nakopoulou, L. ; Gakiopoulou, H. ; Keramopoulos, A. ; Davaris, P.S. ; Pignatelli, M.</creatorcontrib><description>Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was evaluated in 121 breast cancer specimens by immunohistochemistry. Its relationship to clinicopathological features was also investigated.Results Altered β-catenin expression was found in 68% of tumours. Lobular carcinomas showed abnormal β-catenin expression more frequently (77%) than ductal carcinomas (64%) with 46% of lobular cases showing complete absence of β-catenin immunoreactivity. Cytoplasmic β-catenin localization was seen only in ductal carcinomas. Aberrant β-catenin expression was observed in 54% of ductal carcinomas in situ with highly concordant β-catenin expression patterns in the nearby in situ and invasive components. Conclusions Quantitative and qualitative changes in β-catenin expression occur in a considerable proportion of in situ and invasive ductal carcinomas and are more prominent in invasive lobular carcinomas.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1053/ejso.1999.1017</identifier><identifier>PMID: 11237489</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; beta Catenin ; breast cancer ; Breast Neoplasms - chemistry ; Breast Neoplasms - pathology ; Cadherins - analysis ; Carcinoma, Intraductal, Noninfiltrating - chemistry ; Carcinoma, Intraductal, Noninfiltrating - pathology ; Carcinoma, Lobular - chemistry ; Carcinoma, Lobular - pathology ; cell adhesion ; Cytoplasm - chemistry ; Cytoskeletal Proteins - analysis ; ductal carcinoma in situ ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Neoplasm Invasiveness ; Trans-Activators ; β-catenin</subject><ispartof>European journal of surgical oncology, 2001-02, Vol.27 (1), p.31-36</ispartof><rights>2001 Harcourt Publishers Ltd</rights><rights>Copyright Harcourt Publishers Limited.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333</citedby><cites>FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11237489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karayiannakis, A.J.</creatorcontrib><creatorcontrib>Nakopoulou, L.</creatorcontrib><creatorcontrib>Gakiopoulou, H.</creatorcontrib><creatorcontrib>Keramopoulos, A.</creatorcontrib><creatorcontrib>Davaris, P.S.</creatorcontrib><creatorcontrib>Pignatelli, M.</creatorcontrib><title>Expression patterns of β-catenin in in situ and invasive breast cancer</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was evaluated in 121 breast cancer specimens by immunohistochemistry. Its relationship to clinicopathological features was also investigated.Results Altered β-catenin expression was found in 68% of tumours. Lobular carcinomas showed abnormal β-catenin expression more frequently (77%) than ductal carcinomas (64%) with 46% of lobular cases showing complete absence of β-catenin immunoreactivity. Cytoplasmic β-catenin localization was seen only in ductal carcinomas. Aberrant β-catenin expression was observed in 54% of ductal carcinomas in situ with highly concordant β-catenin expression patterns in the nearby in situ and invasive components. Conclusions Quantitative and qualitative changes in β-catenin expression occur in a considerable proportion of in situ and invasive ductal carcinomas and are more prominent in invasive lobular carcinomas.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>beta Catenin</subject><subject>breast cancer</subject><subject>Breast Neoplasms - chemistry</subject><subject>Breast Neoplasms - pathology</subject><subject>Cadherins - analysis</subject><subject>Carcinoma, Intraductal, Noninfiltrating - chemistry</subject><subject>Carcinoma, Intraductal, Noninfiltrating - pathology</subject><subject>Carcinoma, Lobular - chemistry</subject><subject>Carcinoma, Lobular - pathology</subject><subject>cell adhesion</subject><subject>Cytoplasm - chemistry</subject><subject>Cytoskeletal Proteins - analysis</subject><subject>ductal carcinoma in situ</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Trans-Activators</subject><subject>β-catenin</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kEFLwzAUx4Mobk6vHqUnb51JkzbJUcacwsCLnkOavELG1tYkHfq1_CB-JlM68CQEXkJ-7897P4RuCV4SXNIH2IVuSaSU6Un4GZqTkhZ5QUp-juaYM5FzKegMXYWwwxhLyuUlmhFS0PQn52iz_uw9hOC6Nut1jODbkHVN9vOdGx2hdW02neDikOnWpvtRB3eErPagQ8yMbg34a3TR6H2Am1NdoPen9dvqOd--bl5Wj9vcUIZjXjRG0KrgFRhLTUU0M5RXRRqUlbgmtLSMALZcSiywYI2RVFS1Nsw2pm4opQt0P-X2vvsYIER1cMHAfq9b6IagOK6ErDBL4HICje9C8NCo3ruD9l-KYDWqU6M6NapTo7rUcHdKHuoD2D_85CoBYgIg7Xd04FUwDtLy1nkwUdnO_Zf9Cz2kfcw</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Karayiannakis, A.J.</creator><creator>Nakopoulou, L.</creator><creator>Gakiopoulou, H.</creator><creator>Keramopoulos, A.</creator><creator>Davaris, P.S.</creator><creator>Pignatelli, M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Expression patterns of β-catenin in in situ and invasive breast cancer</title><author>Karayiannakis, A.J. ; Nakopoulou, L. ; Gakiopoulou, H. ; Keramopoulos, A. ; Davaris, P.S. ; Pignatelli, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>beta Catenin</topic><topic>breast cancer</topic><topic>Breast Neoplasms - chemistry</topic><topic>Breast Neoplasms - pathology</topic><topic>Cadherins - analysis</topic><topic>Carcinoma, Intraductal, Noninfiltrating - chemistry</topic><topic>Carcinoma, Intraductal, Noninfiltrating - pathology</topic><topic>Carcinoma, Lobular - chemistry</topic><topic>Carcinoma, Lobular - pathology</topic><topic>cell adhesion</topic><topic>Cytoplasm - chemistry</topic><topic>Cytoskeletal Proteins - analysis</topic><topic>ductal carcinoma in situ</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Trans-Activators</topic><topic>β-catenin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karayiannakis, A.J.</creatorcontrib><creatorcontrib>Nakopoulou, L.</creatorcontrib><creatorcontrib>Gakiopoulou, H.</creatorcontrib><creatorcontrib>Keramopoulos, A.</creatorcontrib><creatorcontrib>Davaris, P.S.</creatorcontrib><creatorcontrib>Pignatelli, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karayiannakis, A.J.</au><au>Nakopoulou, L.</au><au>Gakiopoulou, H.</au><au>Keramopoulos, A.</au><au>Davaris, P.S.</au><au>Pignatelli, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression patterns of β-catenin in in situ and invasive breast cancer</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>27</volume><issue>1</issue><spage>31</spage><epage>36</epage><pages>31-36</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was evaluated in 121 breast cancer specimens by immunohistochemistry. Its relationship to clinicopathological features was also investigated.Results Altered β-catenin expression was found in 68% of tumours. Lobular carcinomas showed abnormal β-catenin expression more frequently (77%) than ductal carcinomas (64%) with 46% of lobular cases showing complete absence of β-catenin immunoreactivity. Cytoplasmic β-catenin localization was seen only in ductal carcinomas. Aberrant β-catenin expression was observed in 54% of ductal carcinomas in situ with highly concordant β-catenin expression patterns in the nearby in situ and invasive components. Conclusions Quantitative and qualitative changes in β-catenin expression occur in a considerable proportion of in situ and invasive ductal carcinomas and are more prominent in invasive lobular carcinomas.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>11237489</pmid><doi>10.1053/ejso.1999.1017</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0748-7983 |
ispartof | European journal of surgical oncology, 2001-02, Vol.27 (1), p.31-36 |
issn | 0748-7983 1532-2157 |
language | eng |
recordid | cdi_proquest_miscellaneous_70689604 |
source | Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list) |
subjects | Adult Aged Aged, 80 and over beta Catenin breast cancer Breast Neoplasms - chemistry Breast Neoplasms - pathology Cadherins - analysis Carcinoma, Intraductal, Noninfiltrating - chemistry Carcinoma, Intraductal, Noninfiltrating - pathology Carcinoma, Lobular - chemistry Carcinoma, Lobular - pathology cell adhesion Cytoplasm - chemistry Cytoskeletal Proteins - analysis ductal carcinoma in situ Female Humans Immunohistochemistry Middle Aged Neoplasm Invasiveness Trans-Activators β-catenin |
title | Expression patterns of β-catenin in in situ and invasive breast cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A21%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20patterns%20of%20%CE%B2-catenin%20in%20in%20situ%20and%20invasive%20breast%20cancer&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Karayiannakis,%20A.J.&rft.date=2001-02-01&rft.volume=27&rft.issue=1&rft.spage=31&rft.epage=36&rft.pages=31-36&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1053/ejso.1999.1017&rft_dat=%3Cproquest_cross%3E70689604%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70689604&rft_id=info:pmid/11237489&rfr_iscdi=true |